It is not surprising to observe that the role of a canthin-6-one compound can suppress the production of TNF-α, since blocking signaling of this cytokine using neutralizing antibodies such as adalimumab and its biosimilars is an effective strategy for treating RA [78]. The gene discussed is TNF; the disease is rheumatoid arthritis.